- Home
- TARA vs CTM Comparison
TARA vs CTM Comparison
Compare TARA & CTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- CTM
- Stock Information
- Founded
- TARA N/A
- CTM 2019
- Country
- TARA United States
- CTM United States
- Employees
- TARA N/A
- CTM N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- CTM EDP Services
- Sector
- TARA Health Care
- CTM Technology
- Exchange
- TARA Nasdaq
- CTM Nasdaq
- Market Cap
- TARA 126.5M
- CTM 110.8M
- IPO Year
- TARA N/A
- CTM N/A
- Fundamental
- Price
- TARA $3.33
- CTM $1.32
- Analyst Decision
- TARA Strong Buy
- CTM Strong Buy
- Analyst Count
- TARA 7
- CTM 1
- Target Price
- TARA $20.67
- CTM $3.00
- AVG Volume (30 Days)
- TARA 450.2K
- CTM 3.3M
- Earning Date
- TARA 08-05-2025
- CTM 07-15-2025
- Dividend Yield
- TARA N/A
- CTM N/A
- EPS Growth
- TARA N/A
- CTM N/A
- EPS
- TARA N/A
- CTM N/A
- Revenue
- TARA N/A
- CTM $45,094,164.00
- Revenue This Year
- TARA N/A
- CTM $22.97
- Revenue Next Year
- TARA N/A
- CTM $3.76
- P/E Ratio
- TARA N/A
- CTM N/A
- Revenue Growth
- TARA N/A
- CTM N/A
- 52 Week Low
- TARA $1.60
- CTM $0.12
- 52 Week High
- TARA $10.48
- CTM $2.83
- Technical
- Relative Strength Index (RSI)
- TARA 55.94
- CTM 55.57
- Support Level
- TARA $3.25
- CTM $1.21
- Resistance Level
- TARA $3.23
- CTM $1.34
- Average True Range (ATR)
- TARA 0.17
- CTM 0.11
- MACD
- TARA 0.04
- CTM -0.00
- Stochastic Oscillator
- TARA 81.25
- CTM 44.19
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About CTM Castellum Inc.
Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.